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AbstrACt
Introduction Living donor kidney transplantation 
(LDKT) is the optimal treatment for most patients with 
end-stage renal disease (ESRD). However, there are 
numerous patients who cannot find a living kidney donor. 
Randomised controlled trials have shown that home-
based education for patients with ESRD and their family/
friends leads to four times more LDKTs. This educational 
intervention is currently being implemented in eight 
hospitals in the Netherlands. Supervision and quality 
assessment are being employed to maintain the quality 
of the intervention. In this study, we aim to: (1) conduct a 
cost-effectiveness analysis of the educational programme 
and its quality assurance system; (2) investigate the 
relationship between the quality of the implementation 
of the intervention and the outcomes knowledge, 
communication and LDKT activities; and (3) investigate 
policy implications.
Methods and design Patients with ESRD who do not 
have a living kidney donor are eligible to receive the 
home-based educational intervention. This is carried 
out by allied health transplantation professionals and 
psychologists across eight hospitals in the Netherlands. 
The cost-effectiveness analysis will be conducted with 
a Markov model. Cost data will be obtained from the 
literature. We will obtain the quality of life data from the 
patients who participate in the educational programme. 
Questionnaires on knowledge and communication will be 
used to measure the outcomes of the programme. Data 
on LDKT activities will be obtained from medical records 
up to 24 months after the education. A protocol adherence 
measure will be assessed by a third party by means of a 
telephone interview with the patients and the invitees.
Ethics and dissemination Ethical approval was 
obtained through all participating hospitals. Results will 
be disseminated through peer-reviewed publications and 
scientific presentations. Results of the cost-effectiveness 
of the educational programme will also be disseminated to 
the Dutch National Health Care Institute.
trial registration number NL6529
IntroduCtIon
Living donor kidney transplantation (LDKT) 
is the optimal treatment for most patients 
with end-stage renal disease (ESRD) in terms 
of quality-adjusted life years (QALY), survival 
and cost-effectiveness.1 However, there is a 
significant number of patients who cannot 
find a living kidney donor and many patients 
first undergo dialysis before transplantation 
with a living donor kidney. Interventions are 
needed to improve access to LDKT.
Research has shown that knowledge of 
renal replacement therapies (RRT) and 
communication between patients and their 
social circle play an important role in the 
access to LDKT.2 Studies have shown that a 
home-based interventional programme had 
positive effects for patients with ESRD.3–5 
In our transplant centre in Rotterdam, the 
Netherlands, we have conducted two studies 
on this home-based educational approach: 
one randomised controlled trial (RCT) 
and one cross-over study. The RCT among 
163 patients on dialysis showed significant 
increases in knowledge and communication 
about LDKT among the patients in the exper-
imental arm who received the home-based 
education compared with the standard care 
control arm. Furthermore, there were signifi-
cantly more actual LDKTs in the experimental 
group compared with the control group (17 
vs 4, p=0.003).3
strengths and limitations of this study
 ► Working with a state-transition model involves a 
trade-off between feasibility and transparency of the 
model and the level of details of real life conditions.
 ► We do not have a control group in the implementa-
tion study, we will use the reported effectiveness of 
a randomised controlled trial conducted previously.
 ► By making a dynamic state-transition model, we 
can model the prevalence and incidence of patients 
with end-stage renal disease, and consequently the 
capacity for the facility needs which has not been 
done before.
 ► We have high-quality data at our disposal.
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The cross-over trial was aimed at patients who had not 
previously undergone RRT and who were eligible for 
transplantation. In the first phase, the experimental arm 
received the home-based education while the control 
group waited. In the second phase, the control group 
also received the education. This study also showed that 
there was a statistically significant increase in knowledge 
and communication regarding RRT among patients and 
invitees after receiving the home-based education. Of 
the 80 participants, 49 underwent RRT during the 2-year 
follow-up. Of these, 34 underwent a LDKT, of which 22 
were pre-emptive.4
Given these positive results, a home-based educational 
programme for patients with ESRD and their social 
network is currently being implemented in four regions 
in the Netherlands. Per region, a regional hospital and 
a university transplant hospital are implementing the 
programme. The regional hospitals will target patients 
who are yet to start RRT, while the university hospitals 
will target both these patients and dialysis patients. The 
educators organise the intervention in such a way that 
they will do ‘whatever it takes’, in line with one of the 
basic principles of multisystem therapy (MST), to make 
this event as patient tailored as possible.6 Supervision and 
quality assessment are being employed to maintain the 
quality of the intervention. The first aim of this study is to 
evaluate the cost-effectiveness of the education to support 
continued implementation. In this article, we present 
the study protocol of a cost-effectiveness analysis of the 
educational programme and its quality assurance system. 
The patient population, the standard care, the quality of 
the educations and the setting differ per hospital. There-
fore, our second objective is to investigate the relation-
ship between the quality of the implementation of the 
programme, as measured by protocol adherence, and 
outcome. Outcome is defined in terms of knowledge, 
communication and LDKT activities.
Hypotheses
Previous research has provided convincing evidence that 
transplantation costs less, gives a better survival and a 
higher quality of life compared with dialysis.7–9 We there-
fore hypothesise that the relatively small incremental 
costs of the home-based educational programme should 
be cost-effective. Since it is desirable that in the future 
all waiting list patients can benefit from the effects of the 
home-based intervention, this programme should be part 
of standard care. Hence, a solid basis of the cost-effective-
ness of that educational programme is warranted.
The second hypothesis is that higher protocol adher-
ence among healthcare providers will be associated with 
more positive effects of the educational interventions. 
These effects include an increase in knowledge of renal 
disease and the treatment options, an increase in commu-
nication with family/friends about RRTs, an increase 
in living kidney donation activities and an increase in 
QALYs. If a relationship between protocol adherence and 
effects is shown, a quality assurance system should be an 
inseparable part of the educational programme.
The third hypothesis is that a full implementation of 
the educational programme leads to policy implications 
regarding care for patients with ESRD. Full implemen-
tation may affect the need for dialysis centres and trans-
plantation facilities. By modelling the prevalence we can 
estimate the need for allocating the healthcare budget. 
We aim to present the outcomes of the model in a budget 
impact analysis (BIA).
Thus, the main aim of this article is to discuss the 
protocol of the cost-effectiveness study of the home-based 
educational programme and of the quality assurance 
programme which are currently being implemented in 
the Netherlands. Additionally, potential policy implica-
tions of our hypotheses are discussed in this article.
MEtHods And dEsIgn
Participants and procedure
The implementation study is being conducted in the 
following regions of the Netherlands: Rotterdam, 
Amsterdam, Nijmegen and Groningen.
The home-based educational programme is currently 
being implemented in eight hospitals in the Netherlands; 
four university transplant hospitals and four regional 
hospitals. Regional hospitals were included to reach those 
patients who are yet to start RRT and in this setting, this is 
the target population. In these hospitals, there is a large 
dialysis unit but no transplants are conducted. For these 
hospitals, the inclusion criteria are: ≥18 years of age, are 
eligible for transplantation and primary RRT required 
within the coming 12 months. In the regional hospitals, 
allied health professionals carry out the intervention. The 
four university hospitals incorporate both a dialysis unit 
and a transplant centre, therefore in this setting both 
patients who are yet to start RRT and dialysis patients are 
the target population. Eligible patients for these hospitals 
are required to be ≥18 years, currently undergoing RRT 
or required within the coming 12 months and eligible for 
transplantation. In the university hospitals, allied health 
professionals are accompanied by psychologists to carry 
out the intervention. The distinction between the univer-
sity hospitals and the regional hospitals is in line with the 
protocols of the aforementioned cross-over study and 
the RCT. An estimate of the potential candidates for this 
implementation is about 50 patients per year per univer-
sity centre and 20 patients per regional hospital. The 
implementation study will take 2 years.
If patients have not been able to find living donor candi-
dates in their social network, they will be asked whether 
they and their social network wish to receive home-based 
education from healthcare educators. The nephrologist 
explains to the patients that the educators will provide 
information about renal diseases, the different types of 
RRT and their impact on quality of life. Furthermore, the 
educators can help to discuss the possibilities of living 
donation within the social network of the patient. If the 
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patient consents to the intervention in consultation with 
his/her nephrologist, the healthcare educators contact 
the patient to make an appointment for the first home 
session. Patients are supported in inviting their family/
friends to the second educational session. After comple-
tion of the programme, an evaluation consultation is 
planned with the nephrologist. The number of patients 
who do not consent to participate in the study is recorded, 
as well as the reason for non-participation.
Patient and public involvement
Patients were involved in the design of the educa-
tional programme. When designing the intervention 
we anchored the patient participation in the project 
approach by relying on the results of focus groups among 
50 patients from the intended target group. Their opinion 
was sought regarding two methods described in the liter-
ature of additional information/coaching: (1) an addi-
tional telephone consultation by the transplant doctor10 
and (2) home education where family and friends are 
invited to receive knowledge about RRT. Eighty-eight 
per cent of the participants favoured the home-based 
education over the telephone consultations.11 Addition-
ally, a patient panel and organisations were involved in 
the development of the educational programme protocol 
and materials. Patients were not involved in the design of 
the cost-effectiveness study.
the intervention: home-based education
The intervention consists of two sessions at the patient’s 
home. The intervention is carried out by allied health 
transplantation professionals and psychologists. In the 
first session, the goals of the educational programme are 
discussed and the home-based educational meeting will 
be prepared. The educators will make an inventory of 
individuals in the patient’s social network using a socio-
gram. This helps open the discussion on who to invite for 
the second session, the home-based educational meeting. 
The need for an independent translator is also discussed.
In the second session, the education takes place. The 
educators organise this session in such a way that they will 
do ‘whatever it takes’, in line with one of the basic prin-
ciples of MST, to make this event as patient tailored as 
possible.6 The primary goal of this intervention is educa-
tional, therefore, it is not necessary that all the invitees 
are or become potential donors. The intervention is 
based on the previous RCT and cross-over studies.3 4 A 
more detailed description can be found in a published 
protocol manuscript.12
Measures
Knowledge and communication are evaluated through ques-
tionnaires among all patients and for at least one rela-
tive/friend in attendance at the home-based educational 
session. The knowledge about renal disease and RRTs 
is measured through a validated knowledge question-
naire R3K-T. This 21-item knowledge questionnaire has 
been developed specifically for kidney disease, and has 
good psychometric properties.13 Answer categories are 
multiple choice and the number of correct answers is 
summed. The three-item communication questionnaire 
can be answered on a scale from 1 (completely disagree) 
to 5 (completely agree). An example item is ‘I can talk 
about renal replacement therapies with my loved ones.’ 
Finally, we assess patients’ and invitees’ attitude towards 
RRT through a nine-item questionnaire. This question-
naire can also be answered on a scale from 1 (completely 
disagree) to 5 (completely agree). An item example is ‘I 
am afraid donation will harm the health of the donor.’ 
The administration of questionnaires will take place at 
two occasions: (1) prior to the education either during 
an outpatient visit after signing the ‘informed consent 
form’ or during the first session; and (2) shortly after the 
second session.
Protocol adherence measures: After every completed home 
intervention an independent telephone evaluation is 
conducted with the patient and a relative/friend who 
attended the education programme, to measure the 
degree of protocol adherence of the educators. The inde-
pendence is guaranteed through an independent party, 
specialised in treatment adherence measurement ( www. 
Praktikon. nl). Protocol adherence in this implementa-
tion is defined as the extent to which the different teams 
carry out the educational programme as described in the 
protocol. Measurement is done with an adaptation of the 
‘Treatment Adherence Measures’ (TAM) questionnaire.14 
TAM is scored on a 0–1 scale, where 1 stands for complete 
protocol adherence. The results of the TAM can be used 
for research purposes and to give the educators feedback 
on the quality of their interventions during the imple-
mentation phase.
Cost-effectiveness
Costs
The latest published research on costs of dialysis and 
transplantation in the Netherlands dates back from the 
late 1990s.7 Currently, research on costs of dialysis and 
transplantation is in its final phase. We will use this forth-
coming data (De Wit, personal communication). This cost 
data is of high quality, as it is based on the national data-
base of insurance companies from 2014, which consists 
of records from 99% of all Dutch citizens. Cost calcula-
tions will include costs of dialysis modality, dialysis access, 
transplant procedure, other hospital costs, primary care 
costs, mental healthcare, medication outside the hospital, 
medical devices, healthcare abroad, transport and other 
costs. Healthcare costs for transplantation include prepa-
ratory research, transplant operation, guidance, after 
care, donor expenses, dialysis procedure, other hospital 
costs, primary care, mental healthcare, medication 
outside hospital, medical devices, healthcare abroad, 
transportation and other costs. These include all the 
healthcare costs associated with RRT. Since it is recom-
mended that cost-effectiveness analysis is conducted 
from a societal perspective, we also aim to calculate the 
productivity costs.15 Productivity costs will be estimated 
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with the friction cost method, as recommended in the 
Dutch guidelines for economic evaluation.16 Besides that 
the work situation of patients participating in the study is 
recorded, some research has been done regarding labour 
participation of patients with ESRD.17 18 The costs of the 
home-based intervention and the quality assurance will 
be estimated on the basis of the current practice in the 
implementation. Informal care costs will be estimated 
from the literature.19 The costs of the intervention are 
recorded per centre.
Effects
In health economics the effects of interventions under 
evaluation are preferably expressed in QALYs.15 Research 
on QALYs of different dialysis modalities is wide-
spread,8 20 21 but instruments and patient background 
variables vary. Therefore, we are currently in the process 
of collecting quality of life data from both patients who 
are yet to start RRT and dialysis patients prior to the 
intervention, through the 5-level version of EuroQol-5 
Dimension (EQ-5D-5L), the quality of life instrument 
recommended in the Dutch guidelines for health 
economics.16 We also collect quality of life data from 
patients after the intervention. The educators administer 
the EQ-5D-5L questionnaire to patients at baseline, 6, 12 
and 24 months after the intervention by telephone.
Markov model
To assess the cost-effectiveness of the implementation of 
the home-based educational programme, we will build a 
‘Markov simulation model’. This model will assess the costs 
and effects of ESRD treatments as it simulates the course 
of treatment and disease of the patients. The model will 
have a similar structure as a previously published model 
on this population,7 with some important updates and 
improvements. Unlike that Markov model, which used 
multivariate and univariate sensitivity analyses,7 our model 
will include probabilistic sensitivity analysis using Monte 
Carlo simulation. Consequently, uncertainty of all values 
is considered simultaneously, and the uncertainty in each 
parameter is assumed to possess a probability distribu-
tion.22 The model will run 10 000 simulations in Microsoft 
Excel, V.2010. By using probabilistic sensitivity analyses 
we follow current guidelines in health economics.16 23 24 
A Markov modelling technique is applicable because the 
decision problem involves risk that is continuous over 
time, the timing of events is important and events may 
happen more than once.25 Within a Markov simulation, 
the time horizon of the study is divided into a number 
of discrete time periods, the so-called Markov cycles. A 
Markov process is based on the idea that patients are 
always in a certain disease state and that they can change 
between disease states once during each cycle. By assigning 
effects to each disease state and keeping track of the time 
patients remained in each disease state, long-term effects 
can be calculated. For this cost-effectiveness analysis the 
effects and cost per health state do not change because 
of the intervention. We expect that there will be more 
LDKTs because of the intervention. Therefore, besides 
the costs of the programme, only the transition proba-
bilities will change because of the intervention and will 
be the only difference between the baseline and the post 
implementation situation. Table 1 shows an overview of 
the parameters used and the source.
Model description
A simplified graphical representation of the Markov 
model showing only the treatment categories, rather 
than all the individual Markov states is represented in 
figure 1. Patients continuously enter the model (inflow) 
at the start of the cycle and can start on haemodialysis, 
peritoneal dialysis or transplantation. From there they 
can move between these treatment modalities. Diabetics 
and non-diabetics are modelled separately since the 
transition probabilities between the treatment modali-
ties differ between these groups. Since the incidence of 
kidney failure is increasing, we will also model this in the 
cost-effectiveness analysis. This will be calculated using 
data from the database of Nefrovisie, a large national data-
base with records of patients with ESRD. As stated before, 
the model will include probabilistic sensitivity analysis 
using Monte Carlo simulation. This means that mean 
numbers of patients per year per treatment modality 
will be modelled, and the uncertainty surrounding those 
mean numbers of patients (ie, 95% CIs). Transition prob-
abilities and incidence rates will be based on primary data 
and will include uncertainty. Costs and utilities will be 
Table 1 Overview of parameters and sources in the Markov 
model
Parameter Sources
Costs
1. Medical costs
2. Intervention costs
3. Costs of 
productivity losses
4. Informal care costs
1. Cost study of RRT in the 
Netherlands by de Wit et al 
(forthcoming)
2. Are recorded in the current 
implementation study
3. Work situation of patients is 
recorded in the implementation 
study and use of (Dutch) 
literature.16 17
4. Will be estimated from existing 
literature18
Effects (QALYs) EQ-5D-5L is conducted prior to 
the intervention and 6, 12 and 
24 months after the intervention.
Transition probabilities
1. Between treatment 
modalities
2. Mortality rate
Estimated from the database of 
Nefrovisie
Incidence rates Estimated from the database of 
Nefrovisie
Effect size of the 
intervention
Used from previous studies3 4
EQ-5D-5L, 5-level version of EuroQol-5 Dimension; QALY, quality-
adjusted life years; RRT, renal replacement therapy.
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included in the model as distributions rather than point 
estimates.
Markov states
The Markov states are based on the treatments currently 
available in the Netherlands. These are: full care centre 
haemodialysis, limited care centre haemodialysis, home 
haemodialysis, continuous ambulatory peritoneal dial-
ysis, continuous cyclic peritoneal dialysis, deceased donor 
kidney transplantation and LDKT. Since transition prob-
abilities and costs may differ over time, that is, a patient 
who is in his second year of haemodialysis has a different 
mortality chance than a patient who just started with 
haemodialysis, we will define separate Markov states 
for the first year of treatment and subsequent years of 
treatment for each specific modality. Incident patients 
who enter the model and prevalent patients who switch 
between treatment modalities are assigned to the first 
year Markov states, whereas patients who spend more 
than 1 year in any health state are transferred to the 
subsequent years of that same treatment modality.
Outcomes
The outcome of the implementation will be compared 
with the baseline situation; the situation before this 
programme was implemented. The effect size, in terms of 
an increase in LDKT, will be used from the RCT conducted 
earlier. Through sensitivity analyses an estimation can be 
made of the cost-effectiveness of the intervention whether 
this assumption is either an underestimation or overesti-
mation. A critical assumption will be the extrapolation of 
the effects after the 2 years.
Quality assurance
This study has also implemented a central quality assur-
ance system. We hypothesise that the effectiveness is 
moderated by the protocol adherence of the team of 
healthcare professionals. In the implementation study, it 
might be possible that there are differences in the way 
teams and centres adhere to the protocol. Protocol adher-
ence measures will be assessed by a third party by means 
of a telephone interview with the patients and the invi-
tees. Patients and invitees are asked for their opinion and 
level of satisfaction regarding the way in which the inter-
vention was delivered. Patients and invitees are asked to 
answer the 15-item TAM scoring list. Items are rated on 
a Likert scale (1 not at all to 5 very much). Only items 
that are rated with a 5 will be regarded as fully adherent. 
Items scored with a 1–4 will be regarded as non-adherent. 
The outcome of the protocol adherence will be associ-
ated with the gain in knowledge and communication 
skills. We will also look if there is a correlation between 
the protocol adherence and the amount of LDKTs. A part 
of the quality assurance is a training that all professionals 
who conduct the home interventions must take part in. 
During this training, issues are discussed such as: how to 
convey uniform and complete information to the patient, 
how to behave during the home visits, how to create an 
alignment of the goals of the home visit with the patients, 
how to assist the patient in inviting friends and relatives, 
how to deal with emotional moments, how to discuss deli-
cate topics with respect to individual feelings and opinions 
and, finally, how to ensure no detrimental psychosocial 
effects of the education occur for the patients and his/
her family/friends. All these aspects can be executed in 
different ways by the educators. A supervisor evaluates 
the home visits with each team separately every 6 weeks 
and discuss difficult cases. After these meetings the super-
visor is graded by the educators through a 10-item ques-
tionnaire regarding the content of the teaching and the 
interpersonal delivery of the supervisor. Furthermore, the 
supervisor will bring together all educators for a so-called 
intervision meeting every 3 months. These intervision 
sessions are meant to discuss the home visits with each 
other in order to learn from each other and to keep the 
procedures similar.
dIsCussIon
We presented a protocol for assessing the cost-effective-
ness of our home-based educational programme and its 
generalisability. The implementation of the educational 
programme might both benefit patients and society.
Cost-effectiveness: If indeed our hypotheses are 
confirmed, and the home-based educational programme 
is cost-effective, then there are convincing arguments to 
make the programme standard care in the Netherlands. 
Health insurers already expressed their interest in the 
programme; this implementation study is supported 
by Zorgverzekeraars Nederland (the Netherlands Health 
Insurers), which is the ‘umbrella organization’ of all 
health insurers in the Netherlands. Additionally, the 
Dutch Kidney Foundation supports the programme and 
contributed through three grants in the developmental 
phases of the home-based educational programme. The 
Dutch Kidney Foundation is a non-profit organisation 
which subsidises research and innovation in nephrology 
and renal transplantation care. Indeed, the health insur-
ance companies have good reason to be interested, 
Figure 1 A simplified graphic representation of the Markov 
model with the different health states and the transition 
possibilities between the health states.
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as dialysis is costly. In the Netherlands, 1% of the total 
healthcare budget is spent on patients with ESRD, who 
only constitute 0.0006% of the population.26 27 Further-
more, transplantation is associated with higher quality of 
life for patients with ESRD compared with dialysis treat-
ment. It is therefore valuable, from both patient and 
societal perspective, to conduct a complete and extensive 
cost-effective analysis and consequently to follow-up those 
results in terms of policy.
Quality assurance system
Protocol adherence may be of importance to guarantee 
the effects of the home-based education. First, we expect 
a positive relation of adherence with outcome in terms 
of communication, knowledge and the number of trans-
plantations. Second, any problems or regrets of donors 
and/or patients can only be justified if the evidence-
based protocol was followed. The protocol has also been 
developed after thorough ethical consideration (28), 
which justified all characteristics of the programme. It 
can therefore be argued that health insurance makes 
reimbursement indispensable of the degree of protocol 
adherence of healthcare suppliers. Moreover, they should 
facilitate the quality assurance system as an integral part 
of the programme and ensure that the quality of the 
interventions is independent of the healthcare suppliers.
Limitations
Investigating the (cost-)effectiveness of the home-based 
educational programme has its limitations. In health 
economics modelling, there is always a trade-off between 
the feasibility and transparency of the cost-effectiveness 
model and the level of details of real-life conditions as 
represented in the model. The more details, the more 
the model resembles real life, but the downside is that 
data should be available at that same level of detail and 
that the model becomes too complex in its feasibility. An 
example is that we assume that the mortality on dialysis 
is the same in the second and following years on dial-
ysis. Hence, we know from literature that the mortality 
chance changes, but the data in later years are scarce and 
again the model would become more complex, as more 
‘tunnels states’ have to be introduced. We expect that this 
trade-off will be most prominent in the transition changes 
between health states. We expect less obvious trade-offs 
for costs and utility assessment, as we have sufficient data 
for those variables.
Cooperation
This investigation is a cooperation between many parties, 
who all have expressed their support. Obviously, it is 
possible that this support can be withdrawn for several 
reasons. For instance, we depend on data from a large 
national database with records of patients with ESRD 
(Nefrovisie). Hence, much efforts are and will be put in 
preserving relationships and communication in order to 
maximise fair successful implementation chances for the 
programme.
Ethical considerations
Another challenge that we face is the ethical consider-
ation of promoting living kidney donation through a 
home-based intervention. Previous studies on the ethics 
of this argued that such promotion is justified only when 
the conditions are met, such as (1) participation must be 
completely voluntary throughout the intervention, (2) 
no undue pressure should be put on the participants, 
(3) the education is neutral and non-directive, and (4) 
the purpose and the procedure should be clear to all 
participants.28 29 That does not mean there are no nega-
tive consequences whatsoever, but it does mean that the 
positive outcomes outweigh the negative. It could well be 
that a patient and/or a donor may regret the decision 
to have undertaken a transplantation with a kidney of a 
living donor, and that the donor and/or patient, in hind-
sight, may have felt undue pressure to donate a kidney. 
Adherence to the protocol will minimise these potential 
negative effects. However, it is possible that regret or pres-
sure could lead to negative publicity for the programme. 
That is a risk since such negative publicity could impede 
the chances of implementing the programme as standard 
care.30 Especially considering that deceased organ dona-
tion is currently subject to controversy in the Netherlands 
since the government and parliament have accepted a 
donor law. This law is an opt-out system entailing a positive 
‘no-objection’ deceased donor organ donor registration 
as a default for all Dutch citizens.31 Given this potential 
harm due to negative publicity it is crucial to have (1) 
a protocol which is justifiable from a medical ethical 
perspective, (2) widespread support from the various 
organisations involved, and (3) a high quality in terms of 
protocol adherence and trained adequate educators. If 
these conditions are met, the quality of the process then 
justifies its outcome, which is a subtle trade-off between 
positive and negative outcomes.
Implementation
Another challenge is the generalisability of the results of 
the previous effect study on home-based interventions 
done in Rotterdam. The RCT in the Rotterdam trans-
plant area has shown that the home-based educational 
programme leads up to four times more LDKTs. The trial 
took place at the academic transplant centre (Erasmus 
Medical Centre in Rotterdam) where extensive efforts 
were already undertaken as part of the standard care to 
promote LDKTs.3 32 It is possible that in other transplant 
areas in the Netherlands, with less experience regarding 
promoting LDKT, effectiveness in terms of amount of 
LDKTs may differ. On one hand, this more cautious atti-
tude may lead to lower results than in the Rotterdam trans-
plant area. Hence, organisational conditions within those 
transplant centres may not optimally facilitate the favour-
able results of the interventions. On the other hand, if 
the number of LDKTs was lower than in the Rotterdam 
area, and the uptake of the intervention is high, the effect 
could even be higher than in the Rotterdam area. This is 
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due to a higher effect potential in those centres where 
living donation was not promoted as actively.
Learning curve
As with all new programmes, educators will inherently 
experience a learning curve during the first part of the 
implementation, which could influence the effectiveness 
of the programme. For instance, the goal of 50 patients 
per year per academic transplant centre and the goal of 
20 patients per regional hospital may not be reached. 
Regular supervision (on-the-job) training and peer-to-
peer coaching may help overcome this, but a learning 
curve is unavoidable.
Policy implications
One of the main pillars of an efficient healthcare system 
is the ability to provide effective care to patients when 
needed. It is therefore necessary to have information on 
the effectiveness of the interventions and their cost to 
convince policymakers to reimburse the treatment. If the 
analysis confirms the effectiveness as well as the cost-ef-
fectiveness of the home-based educational programme, 
we recommend that this intervention should be part of 
standard care.
If the home-based educational interventions would 
become standard care, this could have several impli-
cations. First, it can be expected that patients who are 
unable to find a living donor will nevertheless profit 
from an increase number of living kidney donations, as 
the demand for deceased donor kidneys drops. In other 
words, the increase in living donation will further lower 
the waiting list for deceased donor donation as well and 
thereby increase the chance of a deceased donor dona-
tion for those patients without a living donor increases.
Second, the composition of the population of patients 
with ESRD may change. For instance, it can be expected 
that the proportion of patients on dialysis will drop and 
patients with a life-sustaining transplanted kidney will 
increase. This might have an influence on the demand 
for dialysis centres and the need for transplantation facil-
ities. We, therefore, aim to incorporate this in a so-called 
dynamic model to estimate the prevalence over time. 
When modelling the prevalence, we could make esti-
mates of the need for dialysis centres and transplantation 
facilities. However, modelling the facility is surrounded by 
uncertainty. For instance, dialysis centres may have finan-
cial incentives to fulfil dialysis capacity. If this would be 
the case, there will be no monetary benefits for society 
by increasing the transplant facilities if the proportion of 
dialysis capacity remains the same. This would mean that 
there will only be an increase in the average quality of life 
of patients with ESRD.
Finally, a cost-effectiveness analysis only might not be 
sufficient to set policy change in motion. Therefore, 
we anticipate that a policy recommendation accompa-
nied with a BIA will also be required. A BIA addresses 
the expected changes in the expenditure of a healthcare 
system after the adoption of a new intervention. It can 
also be used for budget and resource planning.33 34
ConCLusIon
If our hypotheses are confirmed, we hope by presenting 
an extensive cost-effectiveness analysis, a BIA, and a policy 
recommendation that policy change will be set in motion, 
which again would benefit both patients with ESRD and 
society.
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